1. High number of kinome‐mutations in non‐small cell lung cancer is associated with reduced immune response and poor relapse‐free survival. Issue 1 (21st April 2017) Authors: Helland, Å.; Brustugun, O. T.; Nakken, S.; Halvorsen, A. R.; Dønnem, T.; Bremnes, R.; Busund, L. T.; Sun, J.; Lorenz, S.; Solberg, S. K.; Jørgensen, L. H.; Vodak, D.; Myklebost, O.; Hovig, E.; Meza‐Zepeda, L. A. Journal: International journal of cancer Issue: Volume 141:Issue 1(2017:Jul. 01) Page Start: 184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LBA51Phase 2 trial (BRF113928) of dabrafenib (D) plus trametinib (T) in patients (pts) with previously untreated BRAF V600E–mutant metastatic non-small cell lung cancer (NSCLC). (18th September 2017) Authors: Planchard, D.; Smit, E.F.; Groen, H.J.M.; Mazieres, J.; Besse, B.; Helland, Å.; Giannone, V.; D'Amelio, A.; Zhang, P.; Mookerjee, B.; Johnson, B. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0095: Timing of immunotherapy and SRS – Does it affects the outcome of patients with brain metastases?. (November 2020) Authors: Grøvik, E.; Nilsen, L.; Digernes, I.; Saxhaug, C.; Helland, Å.; Jacobsen, K.D.; Geier, O.; Breivik, B.; Sætre, D.O.; Emblem, K. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-1000 Vascular responses in normal brain tissue after combined immunotherapy and SRS to brain metastases. (April 2019) Authors: Nilsen, L.; Grøvik, E.; Digernes, I.; Saxhaug, C.; Latysheva, A.; Geier, O.; Hellebust, T.P.; Sætre, D.O.; Breivik, B.; Jacobsen, K.D.; Helland, Å.; Emblem, K.E. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real-world data on nivolumab treatment of non-small cell lung cancer. (4th March 2017) Authors: Brustugun, O.T.; Sprauten, M.; Helland, Å. Journal: Acta oncologica Issue: Volume 56:Number 3(2017) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SP-0758: The immune microenvironment in lung cancer - impact on effect of combined radiotherapy and immunotherapy?. (November 2020) Authors: Helland, Å. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗